| Suppression of c‐Myc using 10058‐F4 exerts caspase‐3‐dependent apoptosis and intensifies the antileukemic effect of vincristine in pre‐B acute lymphoblastic leukemia cells N Sheikh‐Zeineddini, D Bashash, A Safaroghli‐Azar, N Riyahi, ... Journal of cellular biochemistry 120 (8), 14004-14016, 2019 | 41 | 2019 |
| Small molecule inhibitor of c-Myc 10058-F4 inhibits proliferation and induces apoptosis in acute leukemia cells, irrespective of PTEN status D Bashash, M Sayyadi, A Safaroghli-Azar, N Sheikh-Zeineddini, N Riyahi, ... The international journal of biochemistry & cell biology 108, 7-16, 2019 | 39 | 2019 |
| Inhibition of PI3K signaling pathway enhances the chemosensitivity of APL cells to ATO: proposing novel therapeutic potential for BKM120 D Bashash, M Delshad, N Riyahi, A Safaroghli-Azar, ... European journal of pharmacology 841, 10-18, 2018 | 22 | 2018 |
| Inhibition of PI3K pathway using BKM120 intensified the chemo-sensitivity of breast cancer cells to arsenic trioxide (ATO) F Alipour, N Riyahi, A Safaroghli-Azar, S Sari, Z Zandi, D Bashash The international journal of biochemistry & cell biology 116, 105615, 2019 | 20 | 2019 |
| Synergistic effects of PI3K and c-Myc co-targeting in acute leukemia: shedding new light on resistance to selective PI3K-δ inhibitor CAL-101 N Riyahi, A Safaroghli-Azar, N Sheikh-Zeineddini, M Sayyadi, D Bashash Cancer investigation 37 (7), 311-324, 2019 | 16 | 2019 |
| Precision medicine highlights dysregulation of the CDK4/6 cell cycle regulatory pathway in pediatric, adolescents and young adult sarcomas F Barghi, HE Shannon, MR Saadatzadeh, BJ Bailey, N Riyahi, ... Cancers 14 (15), 3611, 2022 | 7 | 2022 |
| Integrative multi-OMICs identifies therapeutic response biomarkers and confirms fidelity of clinically annotated, serially passaged patient-derived xenografts established from … PH Pandya, AJ Jannu, K Bijangi-Vishehsaraei, E Dobrota, BJ Bailey, ... Cancers 15 (1), 259, 2022 | 6 | 2022 |
| The effects of Scrophularia striata extract on apoptosis in glioblastoma cells in cell culture F Farahmandzad, R Ahmadi, N Riyahi, E Mahdavi Int J Adv Chem Eng Biol 2 (1), 2015 | 6 | 2015 |
| BET inhibitor increases DNA damage, modulates Wnt signaling, and suppresses osteosarcoma growth in naïve and metastatic disease models N Riyahi, PH Pandya, BJ Bailey, EA Dobrota, C Young, HE Shannon, ... Cancer Research 84 (6_Supplement), 3953-3953, 2024 | | 2024 |
| Therapeutic targeting of BET bromodomain proteins increases DNA damage and potentiates salvage therapy in osteosarcoma xenografts derived from patients with replication stress … N Riyahi, PH Pandya, BJ Bailey, EA Dobrota, C Young, HE Shannon, ... Cancer Research 83 (7_Supplement), 6727-6727, 2023 | | 2023 |
| Osteosarcoma patient-derived xenografts derived from naive and pretreated metastatic patients with high-risk CDK4/6 hyperactivation signatures are sensitive to dual inhibition … F Barghi, MR Saadatzadeh, E Dobrota, R Malko, BJ Bailey, C Young, ... Cancer Research 83 (7_Supplement), 6728-6728, 2023 | | 2023 |
| CDK4/6 inhibitor resistance in relapsed RB-proficient osteosarcoma patient-derived xenografts via PI3 Kinase/mTOR inhibition F Barghi, PH Pandya, MR Saadatzadeh, K Bijangi-Vishehsaraei, ... CANCER RESEARCH 82 (12), 2022 | | 2022 |
| Therapeutic induction of replication stress in the context of salvage therapy in osteosarcoma N Riyahi, PH Pandya, MR Saadatzadeh, K Bijangi-Vishehsaraei, ... Cancer Research 82 (12_Supplement), 2017-2017, 2022 | | 2022 |
| Targeting CDK4/6 inhibitor resistance in relapsed RB-proficient osteosarcoma patient-derived xenografts via PI3 Kinase/mTOR inhibition F Barghi, PH Pandya, MR Saadatzadeh, K Bijangi-Vishehsaraei, ... Cancer Research 82 (12_Supplement), 2011-2011, 2022 | | 2022 |
| DNA Repair Defects in Sarcomas N Riyahi, MR Saadatzadeh, K Bijangi-Vishehsaraei, F Barghi, PH Pandya, ... DNA-Damages and Repair Mechanisms, 2020 | | 2020 |
| cryptococcosis of the brain Menu N Sheikh‐Zeineddini, D Bashash, A Safaroghli‐Azar, N Riyahi, ... | | |
